The Tempus AI, Inc. (NASDAQ: TEM) SEC filings page on Stock Titan provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Tempus is a healthcare technology company that applies artificial intelligence and multimodal data to precision medicine, and its filings offer insight into how it reports financial performance, manages capital, and documents material corporate events.
Investors can review Form 8-K filings where Tempus discloses items such as preliminary financial results, earnings press releases, credit agreement amendments, securities offerings, and other significant developments. For example, Tempus has used 8-K reports to furnish quarterly financial information, describe an automatic shelf registration statement and related prospectus supplement, and detail the terms of its convertible senior notes due 2030, including conversion features, redemption provisions, and associated capped call transactions.
Over time, this page will also surface Tempus’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for its Diagnostics and Data and applications businesses, risk factor discussions, and management’s analysis of operations. In addition, users can expect access to ownership and insider transaction disclosures, such as Form 4 filings, when they are available from EDGAR.
Stock Titan enhances these documents with AI-powered summaries that explain key points from lengthy filings in clear language. Real-time updates from EDGAR help ensure that new TEM filings appear promptly, while AI-generated highlights can draw attention to important terms in credit agreements, securities offerings, or covenant changes. This combination allows readers to navigate Tempus’s regulatory history more efficiently, from capital structure details to ongoing financial reporting.
Tempus AI, Inc. Chief Financial Officer James William Rogers reported an open-market sale of 11,529 shares of Class A Common Stock at $55.00 per share. After this transaction, he directly holds 114,866 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person.
Several holders reported proposed sales of Class A Common Stock of Tempus AI, Inc. The filing lists multiple transactions in April–May 2026, including sales by Eric Lefkofsky (22,335 shares) and related entities Blue Media, LLC and Gray Media, LLC (multiple 133,000 and 33,250 share entries with dollar amounts shown).
TEM: Form 144 filing reporting proposed sale of 11,529 shares of Common Stock arising from Restricted Stock Units dated 05/19/2026. The filing lists prior dispositions by James Rogers of 10,853 shares on 05/19/2026 for $478,291.71 and 2,169 shares on 04/15/2026 for $119,295.00, the latter noted as 10b5-1 sales. The entries identify Morgan Stanley Smith Barney LLC as the broker. This is a routine resale disclosure under Form 144.
Tempus AI, Inc. director David R. Epstein executed a small open-market sale of 250 shares of Class A Common Stock. The shares were sold at a price of $49.40 per share. After this transaction, he directly holds 31,464 shares. The sale was carried out pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on August 27, 2024, indicating it was scheduled in advance rather than timed discretionarily.
Tempus AI, Inc. reported insider activity involving entities associated with CEO and Chairman Eric Lefkofsky. On May 27, 2026, Blue Media, LLC and Gray Media, LLC, entities managed by Lefkofsky, sold a combined 166,250 shares of Class A Common Stock in open-market transactions under a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2025.
Shares were sold at weighted-average prices within ranges disclosed around $45–$47 per share. After these sales, Blue Media, LLC held 15,620,748 shares and Gray Media, LLC held 8,832,851 shares of Tempus AI Class A Common Stock, in addition to other direct and indirect holdings reported for Lefkofsky and related foundations and entities.
Tempus AI, Inc. reports resale notices for Class A Common stock under Rule 144 documenting insider/affiliate sales.
The filings list sales including 22,335 shares by Eric Lefkofsky on 05/19/2026 for $984,303.45, 133,000 shares by Blue Media, LLC on 03/26/2026 for $6,169,148.87 and another 133,000 shares on 04/28/2026 for $6,800,899.01. Additional sales by affiliated entities show proceeds and dates as listed in the notice.
Belcher Eric D reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. director Eric D. Belcher reported an equity compensation grant and his updated shareholdings. He received a grant of 5,913 shares of Class A common stock in the form of restricted stock units at a price of $0.00 per share. These RSUs vest in full on the earlier of the company’s 2027 annual stockholder meeting (or immediately before it if his board service ends at that meeting) or on May 21, 2027, subject to his continuous service. Following the grant, he holds 21,424 Class A shares directly and 14,033 shares indirectly through Nob Hill Ventures LLC, where he has sole investment control and economic interest.
West Nadja reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI director Nadja West received a grant of 5,913 Class A common shares in the form of restricted stock units. This is a compensation-related award with no cash paid by West, and it increases her direct holdings to 37,981 shares after the grant.
The RSUs will vest in full on the earlier of the company’s 2027 annual meeting of stockholders (or immediately before that meeting if her board service ends then) or on May 21, 2027. Vesting is conditioned on her continuous service with Tempus AI through the applicable vesting date.
Leonsis Theodore reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. director Theodore Leonsis reported an equity compensation grant and his current share holdings. He received an award of 5,913 shares of Class A Common Stock in the form of restricted stock units at a stated price of $0.00 per share, increasing his direct holdings to 21,424 shares. The RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting or May 21, 2027, subject to his continued service as a director. In addition, an indirect position of 66,756 Class A Common Stock shares is reported as held by the Theodore J. Leonsis Revocable Trust.
Gottlieb Scott reported acquisition or exercise transactions in this Form 4 filing.
Tempus AI, Inc. director Scott Gottlieb reported receiving an equity award of 5,913 shares of Class A common stock in the form of restricted stock units. These RSUs will vest in full on the earlier of the company’s 2027 annual stockholder meeting or May 21, 2027, subject to his continuous service. Following this grant, he holds 40,749 shares directly.